Search

Search Results
Results 6891 - 6900 of 7381 for autoimmune
  • Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia
    News - 8 Dec 2008
    Genentech, Inc. and Biogen Idec have announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan (rituximab) plus chemotherapy significantly...
  • New analyses of long-term LIALDA (mesalamine) data presented at ACG
    News - 16 Oct 2007
    Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in...
  • Genetic clue found to Chronic Fatigue Syndrome
    News - 24 Apr 2006
    According to researchers from the Centers for Disease Control and Prevention (CDC), in the United States, there may well be a genetic reason why some people develop Chronic Fatigue Syndrome (CFS).
  • Vaccine prevents deadly pneumonia in African children
    News - 28 Mar 2005
    Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae -- a bacterium that causes deadly pneumonia, meningitis and sepsis -- could...
  • Juluca
    Drug - 15 May 2026
    Consumer Medicine Information (CMI) about Juluca intended for persons living in Australia.
  • Cabenuva
    Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Cabenuva intended for persons living in Australia.
  • How Indoor Air Quality and Building Design Shape Human Health
    Health - 20 Apr 2026
    Urban environments shape microbial exposure through building design, occupancy, ventilation, moisture, and contact with green space, with important consequences for infection risk, immune development,...
  • New directions in cell therapy: iPSC platforms and in vivo reprogramming
    White Paper - 6 Apr 2026
    Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science behind these emerging strategies.
  • Edurant
    Drug - 3 Mar 2026
    Consumer Medicine Information (CMI) about Edurant intended for persons living in Australia.
  • Prezista
    Drug - 27 Feb 2026
    Consumer Medicine Information (CMI) about Prezista intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback